Track topics on Twitter Track topics that are important to you
Companies are seeking to capitalize on a hot new gene technology, though a high-stakes patent dispute has yet to be settled. The gene-editing tool, known as Crispr-Cas9, serves as a kind of multipurpose molecular scissors that can cut DNA.
Original Article: Breakthrough Gene Tool Attracts Investors Amid Patent DisputeNEXT ARTICLE
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...